The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1323
October 19, 2009
View Complete Issue         Table of Contents 2019 
Generic Drugs Revisited
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Generic Drugs Revisited
October 19, 2009 (Issue: 1323)
The equivalence of generic drugs to their brand-name precursors continues to be controversial. The last Medical Letter review of this subject (2002) concluded that well-documented therapeutic inequivalence between brand-name and FDA-approved generic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Generic Drugs Revisited
Article code: 1323a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.